These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26652775)

  • 1. The role of next-generation sequencing in understanding the genomic basis of diffuse large B cell lymphoma and advancing targeted therapies.
    Dubois S; Jardin F
    Expert Rev Hematol; 2016 Mar; 9(3):255-69. PubMed ID: 26652775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era.
    Bohers E; Mareschal S; Bertrand P; Viailly PJ; Dubois S; Maingonnat C; Ruminy P; Tilly H; Jardin F
    Leuk Lymphoma; 2015 May; 56(5):1213-22. PubMed ID: 25130477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next generation sequencing and the management of diffuse large B-cell lymphoma: from whole exome analysis to targeted therapy.
    Jardin F
    Discov Med; 2014; 18(97):51-65. PubMed ID: 25091488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma.
    Camus V; Sarafan-Vasseur N; Bohers E; Dubois S; Mareschal S; Bertrand P; Viailly PJ; Ruminy P; Maingonnat C; Lemasle E; Stamatoullas A; Picquenot JM; Cornic M; Beaussire L; Bastard C; Frebourg T; Tilly H; Jardin F
    Leuk Lymphoma; 2016 Sep; 57(9):2171-9. PubMed ID: 26883583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.
    Dubois S; Viailly PJ; Bohers E; Bertrand P; Ruminy P; Marchand V; Maingonnat C; Mareschal S; Picquenot JM; Penther D; Jais JP; Tesson B; Peyrouze P; Figeac M; Desmots F; Fest T; Haioun C; Lamy T; Copie-Bergman C; Fabiani B; Delarue R; Peyrade F; André M; Ketterer N; Leroy K; Salles G; Molina TJ; Tilly H; Jardin F
    Clin Cancer Res; 2017 May; 23(9):2232-2244. PubMed ID: 27923841
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics.
    Cao B; Sun C; Bi R; Liu Z; Jia Y; Cui W; Sun M; Yu B; Li X; Zhou X
    BMC Med Genomics; 2024 Apr; 17(1):84. PubMed ID: 38609996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.
    Karube K; Enjuanes A; Dlouhy I; Jares P; Martin-Garcia D; Nadeu F; Ordóñez GR; Rovira J; Clot G; Royo C; Navarro A; Gonzalez-Farre B; Vaghefi A; Castellano G; Rubio-Perez C; Tamborero D; Briones J; Salar A; Sancho JM; Mercadal S; Gonzalez-Barca E; Escoda L; Miyoshi H; Ohshima K; Miyawaki K; Kato K; Akashi K; Mozos A; Colomo L; Alcoceba M; Valera A; Carrió A; Costa D; Lopez-Bigas N; Schmitz R; Staudt LM; Salaverria I; López-Guillermo A; Campo E
    Leukemia; 2018 Mar; 32(3):675-684. PubMed ID: 28804123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of amplicon-based next-generation sequencing in cancer.
    Chang F; Li MM
    Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment.
    Crombie JL; Armand P
    Hematol Oncol Clin North Am; 2019 Aug; 33(4):575-585. PubMed ID: 31229155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision Medicine for Diffuse Large B-cell Lymphoma.
    Lim MS; Elenitoba-Johnson KS
    Clin Cancer Res; 2016 Jun; 22(12):2829-31. PubMed ID: 26988247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.
    Fontanilles M; Marguet F; Bohers É; Viailly PJ; Dubois S; Bertrand P; Camus V; Mareschal S; Ruminy P; Maingonnat C; Lepretre S; Veresezan EL; Derrey S; Tilly H; Picquenot JM; Laquerrière A; Jardin F
    Oncotarget; 2017 Jul; 8(29):48157-48168. PubMed ID: 28636991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation Profiling of Clinically Advanced Cancers Using Next-Generation Sequencing for Targeted Therapy: A Lifespan Experience.
    Friedman K; Resnick MB; Safran H
    R I Med J (2013); 2015 Oct; 98(10):16-20. PubMed ID: 26422540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of next-generation sequencing in diffuse large B-cell lymphoma.
    Wang Y; Jia S; Cao X; Ge S; Yu K; Chen Y
    Pharmacogenomics; 2023 Jan; 24(1):59-68. PubMed ID: 36661028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mutational Spectrum and Prognosis Analysis of Young Patients with Diffuse Large B-Cell Lymphoma Based on Next-Generation Sequencing].
    Lyu LY; Nie YL; Renaguli A; Qi XL; Muhebaier A; Zhai SS; An L; Mao M; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):403-410. PubMed ID: 37096512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
    Iqbal J; Naushad H; Bi C; Yu J; Bouska A; Rohr J; Chao W; Fu K; Chan WC; Vose JM
    Blood Rev; 2016 Mar; 30(2):73-88. PubMed ID: 26432520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond genomics - Targeting the epigenome in diffuse large B-cell lymphoma.
    Kühnl A; Cunningham D; Chau I
    Cancer Treat Rev; 2017 Sep; 59():132-137. PubMed ID: 28822237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of gene mutation profiles by next-generation sequencing in diffuse large B-cell lymphoma.
    Özçalımlı A; Erdoğdu İH; Turgutkaya A; Yavaşoğlu İ; Döger FK; Bolaman AZ
    Int J Lab Hematol; 2023 Jun; 45(3):310-316. PubMed ID: 36576110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: implications for targeted EZH2 inhibitor therapy?
    Dubois S; Mareschal S; Picquenot JM; Viailly PJ; Bohers E; Cornic M; Bertrand P; Veresezan EL; Ruminy P; Maingonnat C; Marchand V; Lanic H; Penther D; Bastard C; Tilly H; Jardin F
    Oncotarget; 2015 Jun; 6(18):16712-24. PubMed ID: 25762637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.